Channel Therapeutics
Why Robinhood?
You can watch CHRO and buy or sell other stocks, ETFs, and their options commission-free!About CHRO
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil.
CHRO Key Statistics
Stock Snapshot
Channel Therapeutics(CHRO) stock is priced at $13.50, giving the company a market capitalization of 50.2M. It carries a P/E multiple of -0.92.
On 2026-09-08, Channel Therapeutics(CHRO) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 61.13K.
The stock's 52-week range extends from a low of $18.19 to a high of $37.50.
The stock's 52-week range extends from a low of $18.19 to a high of $37.50.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.